(Q37773259)

22 August 2017

1 reference

title

Dendritic cell-based vaccines for the therapy of experimental tumors (English)

1 reference

22 August 2017

1 reference

Elzbieta Pajtasz-Piasecka

series ordinal

1

1 reference

22 August 2017

Marie Indrová

series ordinal

2

1 reference

22 August 2017

language of work or name

1 reference

1 March 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

2

1 reference

22 August 2017

issue

2

1 reference

22 August 2017

page(s)

257-268

1 reference

22 August 2017

cites work

DC-based cancer vaccines

1 reference

Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters

21 January 2018

1 reference

Dendritic-cell-based therapeutic vaccination against cancer

21 January 2018

1 reference

Current approaches in dendritic cell generation and future implications for cancer immunotherapy

21 January 2018

1 reference

Reengineering dendritic cell-based anti-cancer vaccines

21 January 2018

1 reference

Development of dendritic-cell lineages

21 January 2018

1 reference

Dendritic cell subsets in health and disease.

21 January 2018

1 reference

Plasmacytoid dendritic cells take up opsonized antigen leading to CD4+ and CD8+ T cell activation in vivo

21 January 2018

1 reference

Immunotherapy with dendritic cells for cancer

21 January 2018

1 reference

CD83 expression on dendritic cells and T cells: correlation with effective immune responses

21 January 2018

1 reference

In vivo induction of immune responses to pathogens by conventional dendritic cells

21 January 2018

1 reference

DAMPs, PAMPs and alarmins: all we need to know about danger

21 January 2018

1 reference

Mechanisms and consequences of dendritic cell migration

21 January 2018

1 reference

Taking dendritic cells into medicine

21 January 2018

1 reference

Duration, combination and timing: the signal integration model of dendritic cell activation

21 January 2018

1 reference

Toll-like receptors in innate immunity

21 January 2018

1 reference

TLR ligands differentially affect uptake and presentation of cellular antigens

21 January 2018

1 reference

Induction of antigen-specific CD8+ cytotoxic T cells by dendritic cells co-electroporated with a dsRNA analogue and tumor antigen mRNA.

21 January 2018

1 reference

CpG oligodeoxynucleotides as TLR9 agonists: therapeutic applications in cancer.

21 January 2018

1 reference

Intracellular detection and immune signaling pathways of DNA vaccines

21 January 2018

1 reference

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

Dendritic cell-based cancer immunotherapies

21 January 2018

1 reference

The 'kiss of death' by dendritic cells to cancer cells

21 January 2018

1 reference

Dendritic cells: immunobiology and cancer immunotherapy.

21 January 2018

1 reference

Cancer immunotherapy by dendritic cells

21 January 2018

1 reference

Dendritic cells at the interface of innate and acquired immunity: the role for epigenetic changes

21 January 2018

1 reference

Dendritic cells dysfunction in tumour environment

21 January 2018

1 reference

Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies?

21 January 2018

1 reference

Transduction of dendritic cells with Bcl-xL increases their resistance to prostate cancer-induced apoptosis and antitumor effect in mice.

21 January 2018

1 reference

Tumor-infiltrating dendritic cells are potent antigen-presenting cells able to activate T cells and mediate tumor rejection.

21 January 2018

1 reference

Altered macrophage differentiation and immune dysfunction in tumor development

21 January 2018

1 reference

Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.

21 January 2018

1 reference

Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer

21 January 2018

1 reference

Mechanisms and functional significance of tumour-induced dendritic-cell defects

21 January 2018

1 reference

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

21 January 2018

1 reference

Factors influencing the generation of murine dendritic cells from bone marrow: the special role of fetal calf serum

21 January 2018

1 reference

Dendritic cell development: multiple pathways to nature's adjuvants

21 January 2018

1 reference

Dendritic cell immunotherapy: mapping the way.

21 January 2018

1 reference

Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells

21 January 2018

1 reference

Genetically modified dendritic cells for cancer immunotherapy

21 January 2018

1 reference

Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors

21 January 2018

1 reference

Cascades of transcriptional induction during dendritic cell maturation revealed by genome-wide expression analysis

21 January 2018

1 reference

Phenotypical and functional characterization of clinical grade dendritic cells.

21 January 2018

1 reference

Freeze-thawing procedures have no influence on the phenotypic and functional development of dendritic cells generated from peripheral blood CD14+ monocytes.

21 January 2018

1 reference

A protocol for generation of clinical grade mRNA-transfected monocyte-derived dendritic cells for cancer vaccines.

21 January 2018

1 reference

Bacteriophages support anti-tumor response initiated by DC-based vaccine against murine transplantable colon carcinoma

21 January 2018

1 reference

Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines

21 January 2018

1 reference

Induction of protective immunity against MHC class I-deficient, HPV16-associated tumours with peptide and dendritic cell-based vaccines

21 January 2018

1 reference

In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma

21 January 2018

1 reference

Intranodal Administration of Peptide-Pulsed Mature Dendritic Cell Vaccines Results in Superior CD8+T-Cell Function in Melanoma Patients

21 January 2018

1 reference

Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells

21 January 2018

1 reference

In vivo targeting of antigens to human dendritic cells through DC-SIGN elicits stimulatory immune responses and inhibits tumor growth in grafted mouse models

21 January 2018

1 reference

Lentiviral vectors for anti-tumor immunotherapy.

21 January 2018

1 reference

Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors

21 January 2018

1 reference

Cytokine gene-mediated immunotherapy: current status and future perspectives

21 January 2018

1 reference

Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cells

21 January 2018

1 reference

Enhancement of antitumor immunity against B16 melanoma tumor using genetically modified dendritic cells to produce cytokines

21 January 2018

1 reference

Dendritic cell vaccine therapy by immunization with fusion cells of interleukin-2 gene-transduced, spleen-derived dendritic cells and tumour cells

21 January 2018

1 reference

Injection of IL-12 gene-transduced dendritic cells into mouse liver tumor lesions activates both innate and acquired immunity

21 January 2018

1 reference

Immunogenic anti-cancer chemotherapy as an emerging concept

21 January 2018

1 reference

Dendritic cells modified to express fractalkine/CX3CL1 in the treatment of preexisting tumors

21 January 2018

1 reference

Enhancement of anti-tumor immunity specific to murine glioma by vaccination with tumor cell lysate-pulsed dendritic cells engineered to produce interleukin-12.

21 January 2018

1 reference

Interleukin-2 and dendritic cells as adjuvants for surgical therapy of tumours associated with human papillomavirus type 16.

21 January 2018

1 reference

Activation and route of administration both determine the ability of bone marrow-derived dendritic cells to accumulate in secondary lymphoid organs and prime CD8+ T cells against tumors

21 January 2018

1 reference

Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation

21 January 2018

1 reference

Immunosuppressive networks in the tumour environment and their effect in dendritic cells

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1016/J.BBCAN.2008.07.001

12 January 2024

Identifiers

DOI

10.2217/IMT.10.7

1 reference

22 August 2017

1 reference